SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
2022 Biotech Charity Contest
An SI Board Since December 2021
Posts SubjectMarks Bans
267 47 0
Emcee:  technetium Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
217Radio said today that DOW down 200 points, NASADQ down 100%. WHAT? Humorous slitechnetium-12/6/2022
216Next update will arrive soon!!technetium112/6/2022
215Beware Steve: My Contest “hot ones” have typically turned out to be toast. PeaceBulbaMan-12/4/2022
214<<<Is the maximum allocation to a stock pick still 20%?>>>>Steve Lokness-12/4/2022
213Yes, 20% cap still seems reasonable.technetium-12/4/2022
212Hi Technetium Is the maximum allocation to a stock pick still 20%? Many, many thBulbaMan-11/30/2022
211A short, and generally quiet, week for the US Market. The NASDAQ Composite up atechnetium311/28/2022
210A “typically bad” week for the general market (NASDAQ composite off -1.6%). Andtechnetium211/19/2022
209PRVB wins approval for Teplizumab, up over 11% AH: The US FDA has granted apprAloner-11/17/2022
208A good week for the market generally and biotechs tagged along for the ride. Matechnetium211/13/2022
207Interesting indeed. I'm enjoying your updates. It surprised me that the oA.J. Mullen-11/5/2022
206Yah, we know. The Fed raises interest rates (no big surprise) and the markets gtechnetium311/5/2022
205PRVB added another 30% to the upside today on marketing news for Teplizumab and Aloner-11/3/2022
204Just to remind you, last week was good for the NASDAQ composite (+5%), less so ftechnetium210/29/2022
203Ouch.technetium-10/24/2022
202The analyst who downgraded IMUX dropped his target to $5, the lowest of the threA.J. Mullen-10/24/2022
201Every week is special … in its own little way. Last time it was a case of how Btechnetium310/24/2022
200Well, it’s been an interesting week, for two related aspects of the market and ttechnetium210/15/2022
199PRVB added another 12% to last weeks 50%, gain, taking it to a 30% upside for thAloner-10/10/2022
198Immunic, IMUX, announced raising $60m with oversubscription with a premium of 10A.J. Mullen-10/10/2022
197So, after last week’s pretty good, this week we shouldn’t expect much, right? Ttechnetium110/9/2022
196comments that caught my eye from alzforum.org re: lecanemab : CEO Haruo Naitsoftware salesperson110/4/2022
195Another week of bad week in the markets, and I was steeling myself for the fourttechnetium210/3/2022
194CBIO’s special dividend was the result of an asset sale to VRTX netting $60M (prDewDiligence_on_SI19/30/2022
193Okay. Naive question: Why the fat dividend payout? Typically small companies witechnetium-9/30/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News